北美唇疱疹治疗（针对 HSV 1 病毒）市场，按产品类型（药物、软膏、乳霜、药用润唇膏、唇疱疹贴和非药用产品）、给药途径（口服、外用和其他）、类型（处方药和非处方 (OTC) 药）、性别（男性和女性）、药物类型（品牌药和仿制药）、最终用户（医院、专科诊所、家庭护理环境和其他）、分销渠道（医院药房、网上药房、零售药房和其他）划分 - 行业趋势和预测到 2030 年。
北美冷血治疗(HSV 1病毒)
感冒感染的流行率和发病率不断上升,增加了市场需求。 用于改善保健服务的保健支出不断增加也促进了市场增长。 在这一关键时期,主要市场参与者侧重于各种服务启动和批准。 此外,对药物研发和生命科学研究的投资增加,也促使对冷痛治疗的需求增加。
北美(HSV 1病毒的)冷痛治疗市场预计在预测年份会增长,原因是市场参与者增加并可获得先进的服务. 与此同时,制造商还参与研发活动,在市场上推出新产品。 艾滋病毒/艾滋病传播方式的扩散正在进一步促进市场增长。 然而,缺乏对发作和发作寒痛症状及其治疗的认识可能妨碍预测期的市场增长。
北美寒酸治疗(针对HSV 1病毒)市场预计将在2023年至2030年的预测期间获得市场增长. 数据桥市场研究分析认为,在2023年至2030年的预测期间,CAGR增长5.6%,预计到2030年将达到6.9051亿美元,而2022年为4.4654亿美元。
|
报表计量 |
细节 |
|
预测期 |
2023年至2030年统计 |
|
基准年 |
2022 |
|
历史年代 |
2021 (2015-2020年可定制). |
|
数量单位 |
收入(百万美元) |
|
覆盖部分 |
按产品类型(药物、膏剂、奶油、药用唇膏、冷冻补丁和非药物产品),行政路线(Oral、Topical等),类型(处方药药物、性别(男用和女用)、药物类型(干用和普通用药)、终端使用者(医院、专科诊所、家庭护理设施等)、分销渠道(医院药房、在线药房、零售药房等) |
|
涵盖国家 |
美国、加拿大和墨西哥 |
|
覆盖的市场玩家 |
市场上的主要交易公司有GSK plc、Novartis AG、Viatris Inc.、Hikma制药公司PLC、HRA Pharma、Quantum Health、URGO、Apotex Inc.、Church & Dwight Co. Inc.、Bausch保健公司 Inc.、Zydus制药公司、Haleon公司集团、Amparo医疗技术公司、Teva药品美国公司、Carma Labs Inc等。 |
市场定义
口感寒痛或口腔pe疹是由 Her疹Simplex病毒(HSV)所引起感染而发作的小泡状出血. 寒酸一般会出现在面部,唇周围,下巴,颊部和鼻孔上. 通常在爆裂前会引起疼痛和痒痒. HSV是发现影响全球人口的最常见的病毒之一,并且在全世界流行. 全世界多达90%的人至少有一种形式的HSV. 它一般会感染全球的儿科人口,但据卫生组织称,30至49岁的人现在感染病毒的风险较高,HSV的流行率也随着年龄的增长而增加.
北美冷痛治疗(用于HSV 1病毒)
驾驶员
-
日益严重的感冒感染
一群由HSPES Simplex病毒(HSV)引起的小而有伤害的花泡被称作"寒酸". 它们也被称为发烧发泡或口腔疱疹. HSV是发现影响全球人口的最常见的病毒之一,并且是世界范围内的地方性病毒.
比如说,
-
据世卫组织称,全球50岁以下感染HSV-1的人估计超过37亿(67%)
-
根据疾病控制和预防中心(CDC),全国健康和营养检查调查的数据表明,与全球男性相比,HSV-1的流行率高于女性。 艾滋病毒/艾滋病发病率也随着年龄的增长而增加。
-
根据疾控中心的数据,2012年,美国0-49岁人群中的HSV-1流行率包括1.78亿妇女,即49%的妇女人口。
在这些情况下,我们可以得出结论,感冒感染的日益普遍正在推动市场增长。
-
黑道病毒传播方式的扩散
传染性病毒可以以不同的方式传播,从自然储存到易受感染的宿主. HSV感染的传播依赖于受感染者与排出HSV传播模式的人的亲密,个人互动,有不同的分类,包括直接和间接传播.
HSV通常通过直接传输来传递,包括直接接触或滴滴传播. HSV-1传播的主要方式是通过口腔对口接触诱发口腔疱疹感染,在口腔或口腔周围与HSV接触. 此外,不卫生的做法、无保护的性交和口交是增加HSV在人们中的传播的主要方式。 此外,HSV可以通过接吻等接触方式传递,吃同用餐具,分享杯子,毛巾,或从厕所座位上传播,并分享唇膏. 因此,预计传染病传播方式的增加将推动市场增长。
机会
-
增加使用冷冻补丁
越来越多的发冷病例为市场参与者创造了许多机会,并有可能激增对治疗HSV-1感染或相关疾病所需的治疗方案的需求。 由于这个原因,各种关键的市场参与者正在对HSV研究进行更多的投资,以提出新的治疗方案.
在治疗感冒方面正在取得一些技术进步,包括旨在引进治疗感冒的新技术(疫苗、治疗、药物和补丁)的所有医学研究。 人们一直要求补丁能够有效抗寒。
此外,主要市场参与者采取的战略举措将为2023-2030年的预测期提供结构完整性和未来市场增长机会。
重排/挑战
- 对寒酸的发作和症状及其治疗的认识不足
缺乏对发作和发作的发作和发作症状的认识,以及一些被销售的药物的专利终止,会阻碍市场增长率. 此外,与治疗冷痛用药有关的副作用将进一步挑战市场增长。
最近的事态发展
- 2022年10月,GSK plc.和位于美国的精密医学公司Tempus达成了一项为期三年的合作协议,为GSK提供了Tempus的AI启用平台,包括其去识别的患者数据库. 通过其领先的人工智能和机器学习(AI/ML)能力,GSK将与Tempus合作改进临床试验设计,加快招生,并查明药物目标. 这将有助于GSK的研发成功率,并为患者提供更快的个性化治疗.
- 2022年7月,Haleon公司集团宣布完成由GSK集团到Haleon集团的保健业务的附带业务. Haleon是世界领先的消费者健康公司,品牌受到全球数百万消费者的信赖. 其产品范围包括五个主要类别:口腔健康、止痛、呼吸道健康、消化健康等,以及维生素、矿物质和膳食补充剂。 其历史悠久的品牌有:阿德维尔,森索迪内,帕纳多尔,伏尔塔伦,特拉夫卢,奥特里文,波利登特,帕罗多纳克,和克特鲁姆等,其基础是健全的科学,创新,对人的深刻理解.
北美冷痛治疗(HSV 1病毒)市场范围
北美寒酸治疗(针对HSV 1病毒)市场分为产品类型,管理途径,类型,性别,药物类型,最终用户,以及分销渠道. 这些部门的增长将有助于你分析这些行业的微弱增长部门,并为用户提供宝贵的市场概况和市场见解,以便作出战略决定,确定核心市场应用。
产品类型
- 药品
- 药膏
- 奶油
- 药用唇膏
- 冷痛补丁
- 非医疗产品
根据产品类型,市场被分出成药材,膏剂,奶油,药用唇膏,冷酸补丁等非药用产品.
行政路线
- 口头
- 专题
- 其他人员
根据管理路线,市场分为口述、专题等。
类型
- 处方药
- 打击毒品
根据类型,市场分为处方药和Over The Counter(OTC)药物。
性别
- 男性
- 妇女
按性别,市场分为男性和女性。
药物类型
- 品牌
- 常规
基于药物类型,市场被分出为品牌和通用产品.
结束用户
- 医院
- 专科诊所
- 家庭护理设置
- 其他人员
根据最终用户情况,市场分为医院、专科诊所、家庭护理机构等。
分发频道
- 医院药房
- 零售药店
- 在线药店
- 其他人员
根据分销渠道,市场分为医院药房,在线药房,零售药房等.
北美冷血治疗(HSV 1病毒)
北美(针对HSV 1病毒的)冷痛治疗市场进行了分析,并按国家、产品类型、管理路线、类型、性别、毒品类型、最终用户和分销渠道提供了市场规模的见解和趋势。
美国正在北美市场市场份额和市场收入方面占据主导地位,并将在预测期间继续繁荣其支配地位. 这是由于该区域高发性寒酸性感染和快速研发,正在推动市场增长。
报告的国家部分还提供了影响市场的各种因素以及影响市场目前和未来趋势的市场条例变化。 数据点,如新的和替换销售、国家人口统计、疾病流行病学和进出口关税,是用来预测个别国家市场情况的一些主要指针。 此外,在提供国家数据的预测分析的同时,还考虑了北美品牌的存在和可得性以及当地和国内品牌竞争激烈所带来的挑战,以及销售渠道的影响。
(HSV 1病毒)市场份额分析
北美冷痛治疗(针对HSV 1病毒)市场竞争景观提供了竞争对手的细节. 详细情况包括公司概况、公司财务、创收、市场潜力、研发投资、新市场举措、北美存在、生产地点和设施、生产能力、公司优缺点、产品推出、产品宽度和广度以及应用优势。 上述数据点仅涉及公司对市场的关注。
在北美(针对HSV 1病毒)冷痛治疗市场上经营的一些主要角色有GSK plc.,Novartis AG.,Viatris Inc.,Hikma Pharma Procis,HRA Pharma,Quantum Health,URGO,Apotex Inc.,Church & Dwight Co. Inc.,Bausch健康公司,Zydus制药公司,Haleon公司集团,Amparo医疗技术公司,Teva Pharmats USA公司,Carma Labs Inc.和Blistex Inc等.
SKU-
目录
- introduction
- OBJECTIVES OF THE STUDY
- MARKET DEFINITION
- OVERVIEW of NORTH AMERICA Cold Sore Treatment MARKET
- LIMITATIONs
- MARKETS COVERED
- MARKET SEGMENTATION
- MARKETS COVERED
- geographical scope
- years considered for the study
- currency and pricing
- DBMR TRIPOD DATA VALIDATION MODEL
- MULTIVARIATE MODELLING
- THERAPEUTICS LIFELINE CURVE
- primary interviews with key opinion leaders
- DBMR MARKET POSITION GRID
- vendor share analysis
- MARKET drug type COVERAGE GRID
- secondary sourcEs
- assumptions
- EXECUTIVE SUMMARY
- Pipeline analysis
- Epidemiology
- market overview
- drivers
- Growing prevalence of cold sore infection
- Proliferation in modes of transmission of herpes simplex virus
- Increasing awareness about sexually transmitted diseases
- Availability of generic drugs
- Rising rate of HSV infection among women
- RESTRAINTS
- Patent termination of marketed drugs
- Risks of other diseases associated with cold sore
- Dearth of awareness about the onset and symptoms of cold sore treatment
- OPPORTUNITIES
- Increasing disposable income
- Strategic Initiatives by market players
- Increasing research and Development
- Increasing use of cold sore patches
- CHALLENGES
- Rise in alternative treatments
- Emergence of drugs resistant to acyclovir
- Side effects Associated with medications used for treating cold sore
- COVID-19 IMPACT ON COLD SORE TREATMENT MARKET
- impact on price
- Impact on demand
- IMPACT ON SUPPLY CHAIN
- strategic decisions for manufacturers
- CONCLUSION
- north america COLD SORE TREATMENT MARKET, BY strain TYPE
- overview
- HERPES SIMPLEX TYPE 1 VIRUS
- HERPES SIMPLEX TYPE 2 VIRUS
- north america COLD SORE TREATMENT MARKET, BY therapeutics
- overview
- ANTIVIRAL AGENTS
- Acyclovir
- Famciclovir
- Penciclovir
- Valacyclovir
- Docosanol
- ANALGESIC AGENTS
- Carmex
- Herpecin
- others
- others
- north america COLD SORE TREATMENT MARKET, BY drug type
- overview
- generics
- otc
- prescription
- branded
- prescription
- otc
- north america COLD SORE TREATMENT MARKET, BY dosage type
- overview
- Oral
- Tablets
- Pills
- TOPICAL
- cream
- Ointments
- Gel
- spray
- others
- North america COLD SORE TREATMENT MARKET, BY end user
- overview
- HOme care
- HOspitals
- SPECIALTY CLINICS
- OTHERS
- north america COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL
- overview
- Hospitals Pharmacy
- online Pharmacy
- RETAIL Pharmacy
- north america Cold sore treatment market, by country
- overview
- U.S.
- CANADA
- MEXICO
- north america Cold Sore Treatment Market: COMPANY landscape
- company share analysis: north america
- SWOT
- company profile
- GLAXOSMITHKLINE PLC
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- ORTHO DERMATOLOGICS’ (A DIVISION OF BAUSCH HEALTH COMPANIES INC.)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- FOUNDATION CONSUMER HEALTHCARE
- COMPANY SNAPSHOT
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- NOVARTIS AG
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- TEVA PHARMACEUTICALS USA, INC. (A SUBSIDIARY OF TEVA PHARMACEUTICAL INDUSTRIES LTD.)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- AMNEAL PHARMACEUTICALS LLC
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- APOTEX INC.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- AUROBINDO PHARMA USA (A SUBSIDIARY OF AUROBINDO PHARMA)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- CIPLA LIMITED
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- GLENMARK PHARMACEUTICALS, INC., USA (A SUBSIDIARY OF GLENMARK PHARMACEUTICAL LTD.)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- HIKMA PHARMACEUTICALS PLC
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- HRA PHARMA
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- JUBILANT CADISTA (A SUBSIDIARY OF JUBILANT LIFE SCIENCES LIMITED)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- MERIX PHARMACEUTICAL CORP.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- SQAUREX
- 17.15.1 COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- SUN PHARMACEUTICAL INDUSTRIES LTD.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- VIATRIS INC.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Zydus Pharmaceuticals, Inc. (a subsidiary of Zydus Cadila)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- questionnaire
- related reportS
表格列表
TABLE 1 COLD SORE TREATMENT Market, pipeline analysis
TABLE 2 GENERIC DRUGS USED FOR THE TREATMENT OF HSV (COLD SORES)
TABLE 3 north america COLD SORE TREATMENT Market, By strain TYPE 2019-2028 (USD Million)
TABLE 4 north america COLD SORE TREATMENT Market, By THERAPEUTICS 2019-2028 (USD Million)
TABLE 5 north america ANTIVIRAL AGENTS in COLD SORE TREATMENT Market, By therapeutics, 2019-2028 (USD Million)
TABLE 6 north america Analgesic AGENTS in COLD SORE TREATMENT Market, By Therapeutics, 2019-2028 (USD Million)
TABLE 7 north america COLD SORE TREATMENT Market, By drug type 2019-2028 (USD Million)
TABLE 8 north america generics in COLD SORE TREATMENT Market, By drug type, 2019-2028 (USD Million)
TABLE 9 north america branded in COLD SORE TREATMENT Market, By drug type, 2019-2028 (USD Million)
TABLE 10 north america COLD SORE TREATMENT Market, By dosage type 2019-2028 (USD Million)
TABLE 11 north america Oral segment in COLD SORE TREATMENT Market, By dosage type, 2019-2028 (USD Million)
TABLE 12 north america TOPICAL segment in COLD SORE TREATMENT Market, By dosage type, 2019-2028 (USD Million)
TABLE 13 north america COLD SORE TREATMENT Market, By END USER 2019-2028 (USD Million)
TABLE 14 north america COLD SORE TREATMENT Market, By distribution channel 2019-2028 (USD Million)
TABLE 15 north america cold sore treatment market, country, 2021-2028 (USD Million)
TABLE 16 U.S. cold sore treatment market, By strain type , 2021-2028 (USD MILLION )
TABLE 17 U.S. cold sore treatment market, By THERAPEUTICS, 2021-2028 (Usd million )
TABLE 18 U.S. anti-viral agents in cold sore treatment market, By THERAPEUTICS, 2021-2028 (USD MILLION )
TABLE 19 U.S. analgesics agents in cold sore treatment market, By THERAPEUTICS , 2021-2028 (USD Million)
TABLE 20 U.S. cold sore treatment market, By drug Type, 2021-2028 (USD Million)
TABLE 21 U.S. Generics in cold sore treatment market, By drug type, 2021-2028 (USD Million)
TABLE 22 U.S. branded in cold sore treatment market, By drug type , 2021-2028 (USD Million)
TABLE 23 U.S. cold sore treatment market, By dosage type , 2021-2028 (USD Million)
TABLE 24 U.S. oral in cold sore treatment market, By dosage type , 2021-2028 (USD Million)
TABLE 25 U.S. topical in cold sore treatment market, By dosage type, 2018-2027 (USD Million)
TABLE 26 U.S. cold sore treatment market, By end user, 2021-2028 (USD Million)
TABLE 27 U.S. cold sore treatment market, By distribution channel, 2021-2028 (USD Million)
TABLE 28 CANADA cold sore treatment market, By testing Type, 2021-2028 (USD MILLION )
TABLE 29 CANADA cold sore treatment market, By THERAPEUTICS, 2021-2028 (Usd million )
TABLE 30 CANADA anti-viral agents in cold sore treatment market, By THERAPEUTICS, 2021-2028 (USD MILLION )
TABLE 31 CANADA analgesics in cold sore treatment market, By THERAPEUTICS , 2021-2028 (USD Million)
TABLE 32 CANADA cold sore treatment market, By drug type , 2021-2028 (USD Million)
TABLE 33 CANADA generics in cold sore treatment market, By drug type Type, 2021-2028 (USD Million)
TABLE 34 CANADA branded in cold sore treatment market, By drug type, 2021-2028 (USD Million)
TABLE 35 CANADA cold sore treatment market, By dosage type , 2021-2028 (USD Million)
TABLE 36 CANADA oral in cold sore treatment market, By dosage type , 2021-2028 (USD Million)
TABLE 37 CANADA topical in cold sore treatment market, By dosage type , 2021-2028 (USD Million)
TABLE 38 canada cold sore treatment market, By end user, 2021-2028 (USD Million)
TABLE 39 CANADA cold sore treatment market, By distribution channel, 2021-2028 (USD Million)
TABLE 40 MEXICO cold sore treatment market, By strain Type, 2021-2028 (USD MILLION )
TABLE 41 MEXICO Cold sore treatment market, By THERAPEUTICS, 2021-2028 (Usd million )
TABLE 42 MEXICO anti-viral agents in cold sore treatment market, By THERAPEUTICS, 2021-2028 (USD MILLION )
TABLE 43 MEXICO analgesics in cold sore treatment market, By THERAPEUTICS , 2021-2028 (USD Million)
TABLE 44 MEXICO cold sore treatment market, By drug type , 2021-2028 (USD Million)
TABLE 45 MEXICO generics in cold sore treatment market, By drug Type, 2021-2028 (USD Million)
TABLE 46 MEXICO branded in cold sore treatment market, By drug type, 2021-2028 (USD Million)
TABLE 47 MEXICO cold sore treatment market, By dosage type , 2021-2028 (USD Million)
TABLE 48 MEXICO oral in cold sore treatment market, By dosage type , 2021-2028 (USD Million)
TABLE 49 MEXICO topical in cold sore treatment market, By dosage type , 2021-2028 (USD Million)
TABLE 50 Mexico cold sore treatment market, By end user, 2021-2028 (USD Million)
TABLE 51 MEXICO cold sore treatment market, By distribution type, 2021-2028 (USD Million)
图片列表
FIGURE 1 NORTH AMERICA COLD SORE TREATMENT MARKET: SEGMENTATION
FIGURE 2 north america COLD SORE TREATMENT MARKET : DATA TRIANGULATION
FIGURE 3 north america Cold Sore Treatment Market: DROC ANALYSIS
FIGURE 4 north america Cold Sore Treatment market: north america VS country MARKET ANALYSIS
FIGURE 5 north america Cold Sore Treatment Market: COMPANY RESEARCH ANALYSIS
FIGURE 6 north america Cold Sore Treatment MARKET: MULTIVARIATE MODELLING
FIGURE 7 north america Cold Sore Treatment MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 north america COLD SORE TREATMENT MARKET: DBMR MARKET POSITION GRID
FIGURE 9 north america COLD SORE TREATMENT MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 north america Cold Sore Treatment MARKET: MARKET drug type COVERAGE GRID
FIGURE 11 north america Cold Sore Treatment market: SEGMENTATION
FIGURE 12 Growing PREVALENCE OF COLD SORE TREATMENT, AND PROLIFERATION IN MODES OF TRANSMISSION of herpes simplex virus (hsv), and increasing awareness about sexually transmitted diseases are DRIVing THE north america Cold Sore treatment market IN THE FORECAST PERIOD OF 2021 to 2028
FIGURE 13 HERPES SIMPLEX TYPE 1 VIRUS SEGMENT is expected to account for the largest share of the north america COLD SORE TREATMENT MARKET in 2021 & 2028
FIGURE 14 u.s. is the fastest growing market FOR the Cold Sore Treatment MANUFACTURERS IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF NORTH AMERICA COLD SORE TREATMENT MARKET
FIGURE 16 PREVALENCE OF HERPES SIMPLEX VIRUS TYPE 1, AMONG PERSONS AGED 14-49 YEARS, BY AGE GROUP: IN THE U.S. 2015–2016
FIGURE 17 PREVALENCE OF HERPES SIMPLEX VIRUS TYPE 1, BY RACE AND HISPANIC ORIGIN: U.S. 2015–2016
FIGURE 18 north america COLD SORE TREATMENT market: BY strain TYPE, 2020
FIGURE 19 north america COLD SORE TREATMENT market: BY strain TYPE, 2020-2028 (USD Million)
FIGURE 20 north america COLD SORE TREATMENT market: BY strain TYPE, CAGR (2021-2028)
FIGURE 21 north america COLD SORE TREATMENT market: BY strain TYPE, LIFELINE CURVE
FIGURE 22 north america COLD SORE TREATMENT market: BY THERAPEUTICS, 2020
FIGURE 23 north america COLD SORE TREATMENT market: BY THERAPEUTICS , 2020-2028 (USD Million)
FIGURE 24 north america COLD SORE TREATMENT market: BY THERAPEUTICS, CAGR (2021-2028)
FIGURE 25 north america COLD SORE TREATMENT market: BY THERAPEUTICS, LIFELINE CURVE
FIGURE 26 north america COLD SORE TREATMENT market: BY drug type, 2020
FIGURE 27 north america COLD SORE TREATMENT market: BY drug type 2020-2028 (USD Million)
FIGURE 28 north america COLD SORE TREATMENT market: BY drug type, CAGR (2021-2028)
FIGURE 29 north america COLD SORE TREATMENT market: BY drug type, LIFELINE CURVE
FIGURE 30 north america COLD SORE TREATMENT market: BY dosage type, 2020
FIGURE 31 north america COLD SORETREATMENT market: BY dosage type 2020-2028 (USD Million)
FIGURE 32 north america COLD SORETREATMENT market: BY dosage type, CAGR (2021-2028)
FIGURE 33 north america COLD SORETREATMENT market: BY dosage type, LIFELINE CURVE
FIGURE 34 north america COLD SORE TREATMENT market: BY END USER, 2020
FIGURE 35 north america COLD SORE TREATMENT market: BY END USER 2020-2028 (USD Million)
FIGURE 36 north america COLD SORE TREATMENT market: BY END USER, CAGR (2021-2028)
FIGURE 37 north america COLD SORE TREATMENT market: BY END USER, LIFELINE CURVE
FIGURE 38 north america COLD SORE TREATMENT market: BY distribution channel, 2020
FIGURE 39 north america COLD SORE TREATMENT market: BY distribution channel 2020-2028 (USD Million)
FIGURE 40 north america COLD SORE TREATMENT market: BY distribution channel, CAGR (2021-2028)
FIGURE 41 north america COLD SORE TREATMENT market: BY distribution channel, LIFELINE CURVE
FIGURE 42 NORTH AMERICA cold sore treatment market: SNAPSHOT (2020)
FIGURE 43 NORTH AMERICA cold sore treatment market: BY country (2020)
FIGURE 44 NORTH AMERICA cold sore treatment market: BY country (2021 & 2028)
FIGURE 45 NORTH AMERICA cold sore treatment market: BY country (2021 & 2028)
FIGURE 46 NORTH AMERICA cold sore treatment market: BY strain type (2021-2028)
FIGURE 47 north america cold sore treatment market: company share 2020 (%)
研究方法
数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。
DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。
可定制
Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。
